Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Pharmacological interventions for spinal cord injury: where do we stand
PMID 27241382
10.1016/j.fertnstert.2017.01.009 127
Previously, there had only been one oral drug for this indication: metformin, which was approved in 2000
Biochimie 95, 22352245
:max_bytes(150000):strip_icc()/VWH-GettyImages-2059065209-7ab09bdd0be8409493ace4364fccf792.jpg)
To prospectively test the ability of this model to design new peptides with specific activity, we used a simple optimization strategy to design 15 peptides, five in each of three different activity profiles: selective potency at GCGR, selective potency at GLP-1R or high-potency at both receptors
US$ 22.41
US$ 29.31
US$ 20.87
US$ 22.37
US$ 28.85
